Product Code: FBI113276
Growth Factors of medicated feed additives Market
The global medicated feed additives market is projected to witness steady growth over the forecast period. In 2025, the market size was valued at USD 4.19 billion, expected to grow to USD 4.4 billion in 2026, and further reach USD 6.68 billion by 2034, representing a CAGR of 5.37% from 2026-2034. North America dominated the market in 2025 with a 34.51% share, driven by a high livestock population, growing demand for animal protein, supportive government initiatives, and strong R&D activities.
Medicated feed additives are a mixture of animal feed and veterinary medicinal products designed to treat or prevent diseases in livestock, aquaculture species, and pets. These additives are primarily used in poultry, pigs, and fish, where infectious outbreaks are common and difficult to control. The rising global demand for quality animal protein and increasing awareness of animal nutritional requirements are key drivers of market expansion.
Market Drivers
The primary growth driver is the rising demand for animal protein due to population growth and changing dietary patterns. The feedlot industry has expanded to meet this demand, leading key players to increase manufacturing capacity. Strategic acquisitions and product diversification by companies such as Cargill, GrainCorp, and Virbac have further accelerated market growth.
Moreover, increasing government initiatives, such as the National Livestock Mission in India, focus on enhancing animal health, breed improvement, and veterinary care, indirectly boosting demand for medicated feed additives.
Market Restraints
One of the major challenges in the market is antibiotic resistance, resulting from repeated exposure to antimicrobial compounds in feed. This reduces the effectiveness of antibiotics over time and can lead to health risks in humans. Many countries have implemented bans on antibiotic-based feed additives, including India (FSSAI, November 2024), which limits market growth.
Additionally, raw material scarcity, price hikes, and complex regulatory requirements restrict adoption in small and medium-scale farms. Supply chain disruptions, particularly during pandemics or due to active pharmaceutical ingredient shortages, also challenge market stability.
Market Opportunities
The growing pet care and companion animal segment presents opportunities for expansion. Rising pet ownership and disposable incomes are driving demand for medicated feed for dogs and cats. For instance, in February 2025, Virbac launched a Veterinary HPM Digestive Support diet for dogs and cats, addressing digestive issues and recovery needs.
Sustainable development trends also create opportunities, with companies focusing on natural alternatives such as probiotics, prebiotics, and phytogenic feed additives to reduce antimicrobial resistance and improve environmental sustainability.
Market Segmentation
By Type:
- Anticoccidials dominate with 34.80% share in 2026, used widely in poultry and pig farming to improve gut health and nutrient absorption.
- Antiparasitics control internal and external parasites, with increasing collaboration and product development to combat multidrug resistance.
- Antimicrobials remain significant, especially in large-scale livestock farming, with new product launches like Kemin's ENTEROSURE (July 2022).
By Animal Type:
- Livestock dominates with 90.52% share in 2026, including poultry, porcine, and bovine.
- Companion animals are growing moderately due to limited focus and product availability.
By Distribution Channel:
- Veterinary hospitals lead with 45.31% share in 2026, supported by government initiatives and accessibility to licensed veterinarians.
- Veterinary clinics and pharmacies & drug stores maintain stable growth, offering convenience and access to medicated feed products.
Regional Analysis
North America: Market size of USD 1.45 billion in 2025, projected to reach USD 1.44 billion in 2026, driven by high livestock population, government support, and strategic acquisitions like Cargill's U.S. feed mill acquisition in September 2024.
Europe: Second-largest market; the UK and Germany are projected at USD 0.34 billion and USD 0.15 billion by 2026, respectively, supported by strict regulations such as Directive 90/167/EEC and investments like EUPAHW & EU USD 389.6 million (April 2024) for animal health.
Asia Pacific: Fastest-growing region, with Japan, China, and India projected at USD 0.18 billion, USD 0.33 billion, and USD 0.14 billion by 2026, fueled by livestock dependence, rising disposable income, and industry collaborations like Evonik China & Shandong Vland Biotech (October 2023).
Latin America & Middle East/Africa: Stable growth, with investments like JBS's USD 114 million feed factories in Brazil (January 2024), driven by high livestock reliance and meat demand.
Competitive Landscape
The market is consolidated with strong players. Key companies include Cargill, Phibro Animal Health, Kemin Industries, Nutreco, Godrej Agrovet, CHS Inc., Meiji Holdings, and ADM. They focus on strategic collaborations, acquisitions, and product launches to strengthen global presence.
Recent Developments:
- April 2025: Tejo Marine Biotechnology received FDA approval for Faunamor, treating white spot disease in ornamental fish.
- March 2025: TechMix launched an updated colostrum-based equine product line.
- January 2025: Godrej Agrovet launched Argo Rid, a fish lice controller.
Conclusion
The global medicated feed additives market is set to grow from USD 4.19 billion in 2025 to USD 6.68 billion by 2034, at a CAGR of 5.37%. Growth is driven by rising demand for animal protein, advancements in veterinary feed formulations, and government initiatives supporting livestock and pet nutrition. Anticoccidials and livestock segments dominate, while North America leads the market, and Asia Pacific exhibits the highest growth potential. Increasing focus on sustainable feed additives and strategic expansions by major companies will continue to propel the market forward.
Segmentation By Type
- Antimicrobials
- Anticoccidials
- Antiparasitics
- Others
By Animal Type
- Companion
- Feline
- Canine
- Avian
- Others
- Livestock
- Poultry
- Porcine
- Bovine
- Others
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
By Region
- North America (By Type, By Animal Type, By Distribution Channel, By Country)
- Europe (By Type, By Animal Type, By Distribution Channel, By Country/ Sub-Region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Type, By Animal Type, By Distribution Channel, By Country/ Sub-Region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Type, By Animal Type, By Distribution Channel, By Country/ Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, By Animal Type, By Distribution Channel, By Country/ Sub-Region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2025
- 4.2. Regulatory Scenario By Key Countries/ Region, 2025
- 4.3. Pet Ownership Statistics, By Key Countries/ Region, 2025
- 4.4. New Type Launches, By Key Players
- 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.6. Impact of COVID-19 on the Global Medicated Feed Additives Market
5. Global Medicated Feed Additives Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Antimicrobials
- 5.1.2. Anti-coccidials
- 5.1.3. Antiparasitics
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - By Animal Type
- 5.2.1. Companion
- 5.2.1.1. Feline
- 5.2.1.2. Canine
- 5.2.1.3. Avian
- 5.2.1.4. Others
- 5.2.2. Livestock
- 5.2.2.1. Poultry
- 5.2.2.2. Porcine
- 5.2.2.3. Bovine
- 5.2.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.3.1. Veterinary Hospitals
- 5.3.2. Veterinary Clinics
- 5.3.3. Pharmacies & Drug Stores
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast - Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Medicated Feed Additives Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Antimicrobials
- 6.1.2. Anti-coccidials
- 6.1.3. Antiparasitics
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - By Animal Type
- 6.2.1. Companion
- 6.2.1.1. Feline
- 6.2.1.2. Canine
- 6.2.1.3. Avian
- 6.2.1.4. Others
- 6.2.2. Livestock
- 6.2.2.1. Poultry
- 6.2.2.2. Porcine
- 6.2.2.3. Bovine
- 6.2.2.4. Others
- 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.3.1. Veterinary Hospitals
- 6.3.2. Veterinary Clinics
- 6.3.3. Pharmacies & Drug Stores
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Medicated Feed Additives Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Antimicrobials
- 7.1.2. Anti-coccidials
- 7.1.3. Antiparasitics
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - By Animal Type
- 7.2.1. Companion
- 7.2.1.1. Feline
- 7.2.1.2. Canine
- 7.2.1.3. Avian
- 7.2.1.4. Others
- 7.2.2. Livestock
- 7.2.2.1. Poultry
- 7.2.2.2. Porcine
- 7.2.2.3. Bovine
- 7.2.2.4. Others
- 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.3.1. Veterinary Hospitals
- 7.3.2. Veterinary Clinics
- 7.3.3. Pharmacies & Drug Stores
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.4.1. Germany
- 7.4.2. U.K.
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
8. Asia Pacific Medicated Feed Additives Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Antimicrobials
- 8.1.2. Anti-coccidials
- 8.1.3. Antiparasitics
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - By Animal Type
- 8.2.1. Companion
- 8.2.1.1. Feline
- 8.2.1.2. Canine
- 8.2.1.3. Avian
- 8.2.1.4. Others
- 8.2.2. Livestock
- 8.2.2.1. Poultry
- 8.2.2.2. Porcine
- 8.2.2.3. Bovine
- 8.2.2.4. Others
- 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.3.1. Veterinary Hospitals
- 8.3.2. Veterinary Clinics
- 8.3.3. Pharmacies & Drug Stores
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America Medicated Feed Additives Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Antimicrobials
- 9.1.2. Anti-coccidials
- 9.1.3. Antiparasitics
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - By Animal Type
- 9.2.1. Companion
- 9.2.1.1. Feline
- 9.2.1.2. Canine
- 9.2.1.3. Avian
- 9.2.1.4. Others
- 9.2.2. Livestock
- 9.2.2.1. Poultry
- 9.2.2.2. Porcine
- 9.2.2.3. Bovine
- 9.2.2.4. Others
- 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.3.1. Veterinary Hospitals
- 9.3.2. Veterinary Clinics
- 9.3.3. Pharmacies & Drug Stores
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Medicated Feed Additives Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Antimicrobials
- 10.1.2. Anti-coccidials
- 10.1.3. Antiparasitics
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - By Animal Type
- 10.2.1. Companion
- 10.2.1.1. Feline
- 10.2.1.2. Canine
- 10.2.1.3. Avian
- 10.2.1.4. Others
- 10.2.2. Livestock
- 10.2.2.1. Poultry
- 10.2.2.2. Porcine
- 10.2.2.3. Bovine
- 10.2.2.4. Others
- 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.3.1. Veterinary Hospitals
- 10.3.2. Veterinary Clinics
- 10.3.3. Pharmacies & Drug Stores
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Archer Daniels Midland Company (ADM)
- 11.2.1.1. Overview
- 11.2.1.2. Types
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Cargill, Incorporated
- 11.2.2.1. Overview
- 11.2.2.2. Types
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Meiji Holdings Co., Ltd.
- 11.2.3.1. Overview
- 11.2.3.2. Types
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Godrej Agrovet Limited
- 11.2.4.1. Overview
- 11.2.4.2. Types
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Novozymes A/S
- 11.2.5.1. Overview
- 11.2.5.2. Types
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Nutreco
- 11.2.6.1. Overview
- 11.2.6.2. Types
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. CHS Inc.
- 11.2.7.1. Overview
- 11.2.7.2. Types
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Phibro Animal Health Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Types
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Kemin Industries
- 11.2.9.1. Overview
- 11.2.9.2. Types
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Alltech Inc
- 11.2.10.1. Overview
- 11.2.10.2. Types
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)